Clinical Masterclass 2022

Deep dive: case study and treatment options

0:00:00

Introduction

Peter Psaltis

0:02:12

Case study #1

Sandhya Ramakrishna

0:13:12

What should we do about the LDL-C and how?

David Sullivan

0:33:42

The potential of intensively lowering LDL-C in people with PAD

Jonathan Golledge

0:43:15

Should we screen for FH and test for Lp(a)?

Gerald Watts

0:54:44

Discussion

 

1:11:38

Obesity and Diabetes: What’s new?

Elif Ekinci

1:41:39

Triglycerides – to treat or not to treat?

Len Kritharides

2:02:00

Panel Discussion

 

Residual Non-Cholesterol Risk – Chair: Judy de Haan

0:00:00

Introduction – Judy de Haan

 

0:00:22

Overview: Inflammation

Kate Schroder

0:31:30

Colchicine

Sanjay Patel

0:49:18

PET measurements of inflammatory atherosclerosis

Giresh Dwivedi

1:10:02

Clonal Haematopoiesis

Peter Psaltis

1:31:50

Discussion

 

GLP Landscape/SGLT2 Inhibitors

0:00:00

Introduction

Richard O’Brien

0:00:46

Changing trends in the obesity epidemic

Caroline Miller

0:21:44

GLP1 – CV Outcomes

Jonathan Shaw

0:36:32

SGLT2 Inhibitors – CV Outcomes

Samantha Hocking

0:51:28

Discussion

 

Metabolic, non-alcohol fatty liver and cardio renal disease

0:00:00

Introduction

Sophia Zoungas

0:00:30

Polygenic Risk/Genomics

Pradeep Natarajan

0:30:18

Non-Alcoholic Fatty Liver Disease

Catherine Croagh

0:46:30

Chronic Kidney Disease

Carol Pollock

1:02:50

Stroke/COMPASS

Vincent Thijs

1:22:50

Discussion

 

Lipids/Monoclonal

0:00:00

Introduction

Natalie Ward

0:00:24

LPa

Karam Kostner

0:13:40

PCSK9 what is left to answer?

Steve Nicholls

0:29:54

Omega 3 fatty acids

Trevor Mori

1:06:43

Concluding remarks

David Sullivan